Recent studies have demonstrated that S100A10 interacts with annexin A2 (ANXA2) to activate the mTOR pathway, thereby promoting tumor glycolysis and driving malignant tumor progression (Li et al., 2020). This evidence concerns the gene ANXA2 and neoplasm.